Opioid Risk Tool (ORT)
ORT: Opioid Risk Tool
Reprinted With Permission from Lynn Webster, MD
Description
- Length/Time: 5 items, less than 1 minute to administer and score
- Developed by: Webster & Webster, 2005
- Target Population: Adults
- Intended Settings: Primary care
- Assesses: Risk of aberrant behaviors when patients are prescribed opioids for chronic pain
- Administered by: Self-Report
- Copyright: Yes
Evidence
- Provides excellent discrimination between high risk and low risk patients (Passik, et al, 2008).
- Exhibited a high degree of sensitivity and specificity for determining which individuals are at risk for opioid abuse (Webster & Webster, 2005).
- Patients categorized as high-risk on the ORT have an increased likelihood of future abusive drug-related behavior (Chou et al., 2009).
Indications
- Screens for risk of deviant behaviors associated with substance abuse in pain patients.
- Preferable to SOAPP in low-risk populations (Passik, et al, 2008)
Advantages
- Brief, simple scoring tool that is validated in pain populations (Passik, et al, 2008).
- Validated for both male and female patients (Webster & Webster, 2005).
Limitations
- One question on the ORT is limited by the patient's knowledge of family history of substance abuse (Passik, et al, 2008).
- Not validated in non-pain populations.
The Opioid Risk Tool - Online Version
The Opioid Risk Tool - Printable Version
View References
Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline. J Pain. 2009; 10(2): 131-146.
Passik SD, Kirsh KL, Casper D. Addiction-related assessment tools and pain management: instruments for screening, treatment planning and monitoring compliance. Pain Med. 2008; 9: S145-S166.
Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005; 6:432-42.